These label-free impedimetric immunosensors can be possibly useful for monitoring the response to lenalidomide in MM patients by detecting IKZF1 and IKZF3, and maybe later applied for monitoring different immunomodulators or therapeutic agents. The gene discussed is IKZF1; the disease is Miyoshi myopathy.